Literature DB >> 29092942

PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.

Terrence F Meehan1, Nathalie Conte2, Theodore Goldstein3, Giorgio Inghirami4, Mark A Murakami5, Sebastian Brabetz6,7, Zhiping Gu8, Jeffrey A Wiser8, Patrick Dunn8, Dale A Begley9, Debra M Krupke9, Andrea Bertotti10, Alejandra Bruna11, Matthew H Brush12, Annette T Byrne13, Carlos Caldas11, Amanda L Christie5, Dominic A Clark2, Heidi Dowst14, Jonathan R Dry15, James H Doroshow16, Olivier Duchamp17, Yvonne A Evrard18, Stephane Ferretti19, Kristopher K Frese20, Neal C Goodwin21, Danielle Greenawalt22, Melissa A Haendel12, Els Hermans23, Peter J Houghton24, Jos Jonkers25, Kristel Kemper25, Tin O Khor26, Michael T Lewis27, K C Kent Lloyd28, Jeremy Mason2, Enzo Medico10, Steven B Neuhauser9, James M Olson29, Daniel S Peeper25, Oscar M Rueda11, Je Kyung Seong30, Livio Trusolino10, Emilie Vinolo31, Robert J Wechsler-Reya32, David M Weinstock5, Alana Welm33, S John Weroha34, Frédéric Amant25,35, Stefan M Pfister6,7,36, Marcel Kool6,7, Helen Parkinson2, Atul J Butte3, Carol J Bult9.   

Abstract

Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug response and resistance, and tailoring chemotherapeutic approaches for individual patients. The lack of robust standards for reporting on PDX models has hampered the ability of researchers to find relevant PDX models and associated data. Here we present the PDX models minimal information standard (PDX-MI) for reporting on the generation, quality assurance, and use of PDX models. PDX-MI defines the minimal information for describing the clinical attributes of a patient's tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of PDX models in cancer research. Adherence to PDX-MI standards will facilitate accurate search results for oncology models and their associated data across distributed repository databases and promote reproducibility in research studies using these models. Cancer Res; 77(21); e62-66. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 29092942      PMCID: PMC5738926          DOI: 10.1158/0008-5472.CAN-17-0582

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Human cancer growth and therapy in immunodeficient mouse models.

Authors:  Leonard D Shultz; Neal Goodwin; Fumihiko Ishikawa; Vishnu Hosur; Bonnie L Lyons; Dale L Greiner
Journal:  Cold Spring Harb Protoc       Date:  2014-07-01

Review 2.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

Review 3.  Patient-derived tumour xenografts as models for oncology drug development.

Authors:  John J Tentler; Aik Choon Tan; Colin D Weekes; Antonio Jimeno; Stephen Leong; Todd M Pitts; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Nat Rev Clin Oncol       Date:  2012-04-17       Impact factor: 66.675

4.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

5.  NCI Thesaurus: a semantic model integrating cancer-related clinical and molecular information.

Authors:  Nicholas Sioutos; Sherri de Coronado; Margaret W Haber; Frank W Hartel; Wen-Ling Shaiu; Lawrence W Wright
Journal:  J Biomed Inform       Date:  2006-03-15       Impact factor: 6.317

Review 6.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

7.  The promise of patient-derived xenografts: the best laid plans of mice and men.

Authors:  Scott Kopetz; Robert Lemos; Garth Powis
Journal:  Clin Cancer Res       Date:  2012-08-21       Impact factor: 12.531

Review 8.  Patient-derived xenograft models: an emerging platform for translational cancer research.

Authors:  Manuel Hidalgo; Frederic Amant; Andrew V Biankin; Eva Budinská; Annette T Byrne; Carlos Caldas; Robert B Clarke; Steven de Jong; Jos Jonkers; Gunhild Mari Mælandsmo; Sergio Roman-Roman; Joan Seoane; Livio Trusolino; Alberto Villanueva
Journal:  Cancer Discov       Date:  2014-07-15       Impact factor: 39.397

9.  Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data.

Authors:  Warren A Kibbe; Cesar Arze; Victor Felix; Elvira Mitraka; Evan Bolton; Gang Fu; Christopher J Mungall; Janos X Binder; James Malone; Drashtti Vasant; Helen Parkinson; Lynn M Schriml
Journal:  Nucleic Acids Res       Date:  2014-10-27       Impact factor: 16.971

10.  Mouse Tumor Biology (MTB): a database of mouse models for human cancer.

Authors:  Carol J Bult; Debra M Krupke; Dale A Begley; Joel E Richardson; Steven B Neuhauser; John P Sundberg; Janan T Eppig
Journal:  Nucleic Acids Res       Date:  2014-10-20       Impact factor: 16.971

View more
  42 in total

1.  A Melanoma Patient-Derived Xenograft Model.

Authors:  Min Xiao; Vito W Rebecca; Meenhard Herlyn
Journal:  J Vis Exp       Date:  2019-05-20       Impact factor: 1.355

2.  A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant 89Zr-immuno-PET agents.

Authors:  Nikunj B Bhatt; Darpan N Pandya; Stephanie Rideout-Danner; Howard D Gage; Frank C Marini; Thaddeus J Wadas
Journal:  Dalton Trans       Date:  2018-09-04       Impact factor: 4.390

3.  Patient-Derived In Vitro and In Vivo Models of Cancer.

Authors:  Sally E Claridge; Julie-Ann Cavallo; Benjamin D Hopkins
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.

Authors:  Artur A Serebrenik; Prokopios P Argyris; Matthew C Jarvis; William L Brown; Martina Bazzaro; Rachel I Vogel; Britt K Erickson; Sun-Hee Lee; Krista M Goergen; Matthew J Maurer; Ethan P Heinzen; Ann L Oberg; Yajue Huang; Xiaonan Hou; S John Weroha; Scott H Kaufmann; Reuben S Harris
Journal:  Clin Cancer Res       Date:  2020-02-14       Impact factor: 12.531

5.  Leveraging Patient-Derived Models for Immunotherapy Research.

Authors:  Katerina Politi
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-05

6.  FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.

Authors:  Elizabeth A Wellberg; Peter Kabos; Austin E Gillen; Britta M Jacobsen; Heather M Brechbuhl; Stevi J Johnson; Michael C Rudolph; Susan M Edgerton; Ann D Thor; Steven M Anderson; Anthony Elias; Xi Kathy Zhou; Neil M Iyengar; Monica Morrow; Domenick J Falcone; Omar El-Hely; Andrew J Dannenberg; Carol A Sartorius; Paul S MacLean
Journal:  JCI Insight       Date:  2018-07-26

7.  Assessment of IFNγ responsiveness in patient-derived xenografts.

Authors:  Jordan J Cardenas; Camila Robles-Oteiza; Katerina Politi
Journal:  Methods Enzymol       Date:  2019-12-09       Impact factor: 1.600

8.  Translation of DNA Damage Response Inhibitors as Chemoradiation Sensitizers From the Laboratory to the Clinic.

Authors:  Leslie A Parsels; Qiang Zhang; David Karnak; Joshua D Parsels; Kwok Lam; Henning Willers; Michael D Green; Alnawaz Rehemtulla; Theodore S Lawrence; Meredith A Morgan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-01       Impact factor: 7.038

9.  Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer.

Authors:  Xiaoqiang Wang; Karineh Petrossian; Miao-Juei Huang; Kohei Saeki; Noriko Kanaya; Gregory Chang; George Somlo; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2020-11-30       Impact factor: 4.292

10.  Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.

Authors:  Hua Sun; Song Cao; R Jay Mashl; Chia-Kuei Mo; Simone Zaccaria; Michael C Wendl; Sherri R Davies; Matthew H Bailey; Tina M Primeau; Jeremy Hoog; Jacqueline L Mudd; Dennis A Dean; Rajesh Patidar; Li Chen; Matthew A Wyczalkowski; Reyka G Jayasinghe; Fernanda Martins Rodrigues; Nadezhda V Terekhanova; Yize Li; Kian-Huat Lim; Andrea Wang-Gillam; Brian A Van Tine; Cynthia X Ma; Rebecca Aft; Katherine C Fuh; Julie K Schwarz; Jose P Zevallos; Sidharth V Puram; John F Dipersio; Brandi Davis-Dusenbery; Matthew J Ellis; Michael T Lewis; Michael A Davies; Meenhard Herlyn; Bingliang Fang; Jack A Roth; Alana L Welm; Bryan E Welm; Funda Meric-Bernstam; Feng Chen; Ryan C Fields; Shunqiang Li; Ramaswamy Govindan; James H Doroshow; Jeffrey A Moscow; Yvonne A Evrard; Jeffrey H Chuang; Benjamin J Raphael; Li Ding
Journal:  Nat Commun       Date:  2021-08-24       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.